XML 43 R30.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Acquisitions (Tables)
12 Months Ended
Dec. 31, 2016
Business Combinations [Abstract]  
Summary of Company's Preliminary Allocation of Purchase Price

The Company’s preliminary allocation of purchase price is as follows (in thousands):

 

     Third-Party
Receivables
Acquisition
     Other
Acquisitions
     Total  

Current assets

   $ 17,819       $ 200       $ 18,019   

Property and equipment

     5,807         866         6,673   

Other noncurrent assets

     115         689         804   

Goodwill

     190,977         299,005         489,982   

Other intangible assets

     221,870         82,756         304,626   

Current liabilities

     (5,863      (333      (6,196

Deferred income tax liabilities—long-term

     (31,114      (22,388      (53,502

Other long-term liabilities

     (829      —           (829
  

 

 

    

 

 

    

 

 

 
   $ 398,782       $ 360,795       $ 759,577   
  

 

 

    

 

 

    

 

 

 

Schedule of Pro Forma Information Combines Consolidated Results of Company and Business Acquisitions

The following unaudited pro forma information combines the consolidated results of operations of the Company on a GAAP basis and the acquisitions completed during 2016 and 2015, including adjustments for pro forma amortization and interest expense, as if the transactions had occurred on January 1, 2015 and January 1, 2014, respectively (in thousands, except per share data):

 

     Years Ended December 31,  
     2016      2015  

Pro forma net revenue

   $ 3,336,120       $ 3,276,266   

Pro forma net income

     329,720         348,788   

Pro forma net income per common share (1):

     

Basic

   $ 3.57       $ 3.75   

Diluted

   $ 3.54       $ 3.71   

Weighted average common shares (1):

     

Basic

     92,422         93,077   

Diluted

     93,109         93,960   

 

(1) The comparison of net income per common share is affected by the changes in the number of weighted average shares outstanding in each period.